Swiss Re AG

SWX:SREN Stock Report

Market Cap: CHF 36.9b

Swiss Re Valuation

Is SREN undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of SREN when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: SREN (CHF127.2) is trading below our estimate of fair value (CHF350.45)

Significantly Below Fair Value: SREN is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for SREN?

Key metric: As SREN is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for SREN. This is calculated by dividing SREN's market cap by their current earnings.
What is SREN's PE Ratio?
PE Ratio14.2x
EarningsUS$2.94b
Market CapUS$41.67b

Price to Earnings Ratio vs Peers

How does SREN's PE Ratio compare to its peers?

The above table shows the PE ratio for SREN vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average24.1x
ZURN Zurich Insurance Group
18.2x8.4%CHF 78.8b
SLHN Swiss Life Holding
18.8x2.9%CHF 20.4b
HELN Helvetia Holding
29.5x14.3%CHF 8.0b
BALN Baloise Holding
29.9x15.6%CHF 7.6b
SREN Swiss Re
14.2x12.8%CHF 36.9b

Price-To-Earnings vs Peers: SREN is good value based on its Price-To-Earnings Ratio (14.2x) compared to the peer average (24.1x).

Price to Earnings Ratio vs Industry

How does SREN's PE Ratio compare vs other companies in the European Insurance Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
SREN 14.2xIndustry Avg. 11.7xNo. of Companies12PE0816243240+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: SREN is expensive based on its Price-To-Earnings Ratio (14.2x) compared to the European Insurance industry average (11.7x).

Price to Earnings Ratio vs Fair Ratio

What is SREN's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

SREN PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio14.2x
Fair PE Ratio19.4x

Price-To-Earnings vs Fair Ratio: SREN is good value based on its Price-To-Earnings Ratio (14.2x) compared to the estimated Fair Price-To-Earnings Ratio (19.4x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst SREN forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentCHF 127.20
CHF 129.65
+1.9%
12.7%CHF 159.92CHF 98.56n/a16
Nov ’25CHF 111.90
CHF 119.57
+6.9%
13.5%CHF 140.46CHF 85.43n/a16
Oct ’25CHF 115.35
CHF 116.54
+1.0%
14.6%CHF 139.85CHF 81.35n/a16
Sep ’25CHF 115.70
CHF 115.16
-0.5%
14.7%CHF 140.41CHF 81.67n/a15
Aug ’25CHF 108.45
CHF 115.40
+6.4%
13.1%CHF 135.37CHF 85.23n/a15
Jul ’25CHF 112.40
CHF 114.75
+2.1%
12.9%CHF 135.03CHF 83.20n/a15
Jun ’25CHF 114.70
CHF 114.27
-0.4%
13.0%CHF 135.08CHF 84.97n/a15
May ’25CHF 99.82
CHF 111.89
+12.1%
13.0%CHF 135.71CHF 85.41n/a15
Apr ’25CHF 115.95
CHF 111.06
-4.2%
12.8%CHF 133.16CHF 88.34n/a15
Mar ’25CHF 106.30
CHF 107.85
+1.5%
12.4%CHF 130.56CHF 86.62n/a16
Feb ’25CHF 97.76
CHF 104.61
+7.0%
11.4%CHF 124.91CHF 84.51n/a16
Jan ’25CHF 94.56
CHF 100.26
+6.0%
11.3%CHF 121.77CHF 80.54n/a16
Dec ’24CHF 98.34
CHF 102.05
+3.8%
12.3%CHF 125.86CHF 82.24n/a16
Nov ’24CHF 100.95
CHF 99.67
-1.3%
14.3%CHF 129.31CHF 77.58CHF 111.9016
Oct ’24CHF 94.32
CHF 99.63
+5.6%
13.8%CHF 131.28CHF 78.76CHF 115.3516
Sep ’24CHF 85.64
CHF 97.20
+13.5%
15.9%CHF 141.11CHF 75.60CHF 115.7016
Aug ’24CHF 90.90
CHF 95.45
+5.0%
12.6%CHF 117.01CHF 73.53CHF 108.4516
Jul ’24CHF 90.04
CHF 97.20
+7.9%
12.7%CHF 120.46CHF 75.70CHF 112.4017
Jun ’24CHF 92.78
CHF 97.12
+4.7%
13.0%CHF 121.81CHF 76.54CHF 114.7018
May ’24CHF 89.72
CHF 94.27
+5.1%
13.2%CHF 116.06CHF 72.45CHF 99.8218
Apr ’24CHF 93.84
CHF 94.61
+0.8%
13.5%CHF 118.61CHF 74.03CHF 115.9518
Mar ’24CHF 97.50
CHF 96.96
-0.6%
13.5%CHF 121.97CHF 76.14CHF 106.3018
Feb ’24CHF 94.38
CHF 89.55
-5.1%
11.9%CHF 111.93CHF 70.65CHF 97.7618
Jan ’24CHF 86.48
CHF 81.34
-5.9%
12.3%CHF 107.08CHF 62.94CHF 94.5618
Dec ’23CHF 84.98
CHF 80.28
-5.5%
11.7%CHF 108.23CHF 63.62CHF 98.3418
Nov ’23CHF 74.72
CHF 83.02
+11.1%
14.0%CHF 115.52CHF 54.30CHF 100.9519

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

Hannover Rück

€28.9b

Provides reinsurance products and services in Germany, the United Kingdom, France, Europe, the United States, Asia, Australia, Africa, and internationally.

HNR1

€159.00

7D

0%

1Y

0%

Vaudoise Assurances Holding

CHF 1.4b

Provides insurance products and services primarily in Switzerland.

VAHN

CHF 469.00

7D

0.9%

1Y

11.7%

Chubb

US$114.0b

Provides insurance and reinsurance products worldwide.

4432874

US$250.00

7D

0%

1Y

23.6%